These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15363616)

  • 1. [Anti-Ku antibodies. Study of prévalence and of clinical meaning].
    Beyne-Rauzy O; Couret B; Fortenfant F; Adoue D
    Rev Med Interne; 2004 Sep; 25(9):619-22. PubMed ID: 15363616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoimmune diseases with the presence of anti-ku antibodies - analysis of three cases].
    Wielosz E; Majdan M; Jeleniewicz R; Mazurek M
    Wiad Lek; 2016; 69(1):24-6. PubMed ID: 27162291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.
    Cavazzana I; Ceribelli A; Quinzanini M; Scarsi M; Airò P; Cattaneo R; Franceschini F
    Lupus; 2008 Aug; 17(8):727-32. PubMed ID: 18625650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against Ku protein in sera from patients with autoimmune diseases.
    Yaneva M; Arnett FC
    Clin Exp Immunol; 1989 Jun; 76(3):366-72. PubMed ID: 2665976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ku autoantibodies: series of 5 cases.
    Gryga K; Milewski M; Zółciński M; Dyczek A; Musiał J
    Pol Arch Med Wewn; 2009; 119(1-2):95-7. PubMed ID: 19341186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Ku antibodies: Clinical, genetic and diagnostic insights.
    Belizna C; Henrion D; Beucher A; Lavigne C; Ghaali A; Lévesque H
    Autoimmun Rev; 2010 Aug; 9(10):691-4. PubMed ID: 20621654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.
    Rigolet A; Musset L; Dubourg O; Maisonobe T; Grenier P; Charuel JL; Behin A; Herson S; Amoura Z; Benveniste O
    Medicine (Baltimore); 2012 Mar; 91(2):95-102. PubMed ID: 22391471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
    Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
    Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and serological associations of anti-Ku antibody.
    Cooley HM; Melny BJ; Gleeson R; Greco T; Kay TW
    J Rheumatol; 1999 Mar; 26(3):563-7. PubMed ID: 10090163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti PM-Scl antibodies. Study of prevalence and of meaning].
    Gaudin C; Fortenfant F; Adoue D; Beyne-Rauzy O
    Rev Med Interne; 2006 Sep; 27(9):665-70. PubMed ID: 16797795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of anti-Ku autoantibodies--a serologic marker of overlap syndrome?
    Mimori T
    Intern Med; 2002 Dec; 41(12):1096-8. PubMed ID: 12521194
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of anti-Ku antibodies].
    Mimori T; Suwa A; Hama N
    Nihon Rinsho; 1990 Feb; 48 Suppl():535-8. PubMed ID: 2113133
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of antigen selectivity in autoimmune responses to the Ku (p70/p80) antigen.
    Reeves WH; Sthoeger ZM; Lahita RG
    J Clin Invest; 1989 Aug; 84(2):562-7. PubMed ID: 2527251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood-Onset Anti-Ku Antibody-Positive Generalized Morphea with Polymyositis: A Japanese Case Study.
    Kishi T; Miyamae T; Morimoto R; Ishiguro N; Hamaguchi Y; Fujimoto M; Nagata S; Yamanaka H
    Pediatr Dermatol; 2015; 32(5):e224-5. PubMed ID: 26205636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-Ku antibodies].
    Hirakata M; Suwa A
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():572-4. PubMed ID: 20942132
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
    Koenig M; Fritzler MJ; Targoff IN; Troyanov Y; Senécal JL
    Arthritis Res Ther; 2007; 9(4):R78. PubMed ID: 17688695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic tests: Anti-Ku antibodies].
    Suwa A
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():523-5. PubMed ID: 16111320
    [No Abstract]   [Full Text] [Related]  

  • 20. Case of diffuse cutaneous systemic sclerosis with anti-Ku and anti-centromere antibodies.
    Ohashi S; Ueda-Hayakawa I; Isei T; Okamoto H
    J Dermatol; 2013 Jul; 40(7):558-61. PubMed ID: 23663134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.